Download MendeleyTMPRSS2-mediated coronavirus spike activation and inhibition.
McCallum, M., Case, J.B., Brown, J.T., Park, Y.J., Lee, J., Sutherland, E., Aggarwal, A., Gibson, C., Lempp, F.A., Stewart, C., Tortorici, M.A., Sanapala, S., Low, J.S., Asarnow, D., Bohan, D., Dellota Jr., E., Merz, B., Chawla, B., Kar, S., Lanzavecchia, A., Sallusto, F., Riley, N.M., Turville, S., Purcell, L., Diamond, M.S., Veesler, D.(2026) Nat Struct Mol Biol
- PubMed: 42050172 Search on PubMedSearch on PubMed Central
- DOI: https://doi.org/10.1038/s41594-026-01801-y
- Primary Citation Related Structures:
11HK, 11HL, 11HN, 11HW, 9OPQ, 9OPR, 9YYU, 9YYV, 9Z3J, 9Z3K - PubMed Abstract:
The protease TMPRSS2 facilitates coronavirus infections, yet its mechanism of viral glycoprotein recognition remains unclear. Here we show that, following ACE2 engagement of the SARS-CoV-2 spike (S) inducing the early fusion intermediate conformation (E-FIC), TMPRSS2 cleaves the R815 S 2 ' site and promotes fusogenic conformational changes leading to viral entry. We unveil TMPRSS2 recognition of S 2 ', identify key residues modulating binding specificity and demonstrate that S 2 ' site-directed broadly neutralizing antibodies target E-FIC and inhibit viral entry by blocking TMPRSS2 access. We computationally designed stabilized E-FIC as a vaccine candidate, overcoming the transient nature of this state. We describe a TMPRSS2-directed monoclonal antibody inhibiting several coronaviruses, including SARS-CoV-2 variants and protecting mice against SARS-CoV-2 challenge. These results outline the mechanistic role of TMPRSS2 and S 2 ' site-directed antibodies in coronavirus entry.
- Department of Biochemistry, University of Washington, Seattle, WA, USA.
Organizational Affiliation:
